Vertex Pharmaceuticals, Inc. (VRTX) Blows Up Q3 Estimates
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $528.19 +2.45%
Financial Fact:
Sales, general and administrative expenses: 106.06M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Sales, general and administrative expenses: 106.06M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q3 EPS of $0.70, $0.53 better than the analyst estimate of $0.17. Revenue for the quarter came in at $659.2 million versus the consensus estimate of $343.42 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
